Background: Superior vena cava syndrome is uncommon after cardiac surgery, because the formation of thrombus after cardiopulmonary bypass rarely occurs. Case presentation: Herein, we present a case of a patient with dynamic severe mitral regurgitation after aortic valve replacement. Whereas the treatment of this disorder was a challenge, the real complication, an early-onset and massive thrombo...

We report the first case of successful surgical resection of a malignant phaeochromocytoma with tumour extension into vena cava and right atrium in a patient with multiple endocrine neoplasia type 2A. A 21-year-old woman with genetic confirmation of multiple endocrine neoplasia type 2A syndrome was diagnosed with a very rare case of malignant phaeochromocytoma with tumour thrombus extension int...

Superior vena cava syndrome is caused by obstruction of the superior vena cava due to a variety of malignant and benign entities. The most common malignant entities are lung cancer and mediastinal tumor. Conventional treatments include bypass surgery, external beam radiation therapy, chemotherapy, and medical treatment. In this report, we performed an intravascular metallic stent deployment and...

INTRODUCTION Pacemaker induced superior vena cava syndrome is an unusual complication of pacemaker implantation. Endothelial damage caused by repeated trauma from the lead is thought to be responsible for the stenosis. Malignancy has been historically the most common etiology. However, the increase in use of indwelling venous catheters and cardiac pacemaker has resulted in more patients with su...

Hunter' was the first to report a case of superior vena cava obstruction. Ehlrich2 et al. and McIntire and Sykes3 have extensively reviewed the world literature. Obstruction of the superior vena cava due to primary endothoracic malignant tumours or aneurysm is not uncommon, accounting for 94 per cent. of our cases, but benign lesions causing obstruction of this vessel are rare Oschner and Dixon...

AIM The aim of this study was to report our experience with palliative stent treatment of superior vena cava syndrome. METHODS Between January 2008 and December 2009, 30 patients (mean age 60.7 years) were treated with stents because of stenosed superior vena cava. All patients presented clinically with superior vena cava syndrome and according caval stenosis confirmed by computed tomography....

Superior vena cava obstruction leads to the venous hypertension of the head, neck, upper extremities and upper part of the truncus. Its clinical manifestation, known as the superior vena cava syndrome, is a complication of malignancy, mainly of lung cancer and lymphoma. As it usually affects patients with advanced disease, the prognosis is poor. This article stresses the importance of early det...

Persistent left superior vena cava with absent right superior vena cava is a very rare venous anomaly and is known as isolated PLSVC. It is usually an asymptomatic anomaly and is mostly detected during difficult central venous access or pacemaker implantation, though it could also be associated with an increased incidence of congenital heart disease, arrhythmias, and conduction disturbances. He...